医学
肾毒性
范科尼综合征
肾功能
骨软化症
养生
内科学
急性肾损伤
埃法维伦兹
肾
泌尿科
胃肠病学
人类免疫缺陷病毒(HIV)
维生素D与神经学
免疫学
抗逆转录病毒疗法
病毒载量
作者
Bhargavi Kumar,Rajgokul Prabhakar,Saravanan Thangavelu
标识
DOI:10.4997/jrcpe.2020.316
摘要
Tenofovir disoproxil fumarate (TDF) is the foundation nucleotide reverse-transcriptase inhibitor in the recommended first-line regimen for all naive human immunodeficciency virus-1 (HIV-1) patients whose age is more than 10 years and body weight is more than 30 kg. Although it has a good safety profile overall, nephrotoxicity is a concern and its overall incidence is 1-6% with a long period of clinical latency. Nephrotoxicity may manifest as either proximal renal tubule dysfunction in the form of a partial or complete Fanconi syndrome or as decreased renal function leading to acute or chronic kidney injury. Osteomalacia can also develop secondary to complicating hypophosphataemia and low calcitriol levels. Here we report a 50-year-old HIV-positive male on tenofovir who presented with proximal renal tubular acidosis and fracture of left neck of femur four years after initiation of the drug.
科研通智能强力驱动
Strongly Powered by AbleSci AI